India · Delayed Price · Currency is INR CTI BioPharma Statistics
Total Valuation
NSE:JISLDVREQS has a market cap or net worth of INR 37.50 billion. The enterprise value is 77.87 billion.
| Market Cap | 37.50B |
| Enterprise Value | 77.87B |
Important Dates
The next estimated earnings date is Thursday, August 7, 2025.
| Earnings Date | Aug 7, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 19.29M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -4.01% |
| Shares Change (QoQ) | -1.22% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 518.57M |
Valuation Ratios
The trailing PE ratio is 110.67.
| PE Ratio | 110.67 |
| Forward PE | n/a |
| PS Ratio | 0.64 |
| PB Ratio | 0.65 |
| P/TBV Ratio | 0.69 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 229.83 |
| EV / Sales | 1.33 |
| EV / EBITDA | 10.49 |
| EV / EBIT | 16.18 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.69 |
| Debt / EBITDA | 5.40 |
| Debt / FCF | n/a |
| Interest Coverage | 1.08 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 3.10% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 7.00M |
| Profits Per Employee | 40,560 |
| Employee Count | 8,353 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, NSE:JISLDVREQS has paid 272.10 million in taxes.
| Income Tax | 272.10M |
| Effective Tax Rate | 52.47% |
Stock Price Statistics
The stock price has decreased by -28.41% in the last 52 weeks. The beta is -0.06, so NSE:JISLDVREQS's price volatility has been lower than the market average.
| Beta (5Y) | -0.06 |
| 52-Week Price Change | -28.41% |
| 50-Day Moving Average | 31.77 |
| 200-Day Moving Average | 32.24 |
| Relative Strength Index (RSI) | 27.70 |
| Average Volume (20 Days) | 25,659 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:JISLDVREQS had revenue of INR 58.47 billion and earned 338.80 million in profits. Earnings per share was 0.49.
| Revenue | 58.47B |
| Gross Profit | 24.74B |
| Operating Income | 4.80B |
| Pretax Income | 518.60M |
| Net Income | 338.80M |
| EBITDA | 7.41B |
| EBIT | 4.80B |
| Earnings Per Share (EPS) | 0.49 |
Balance Sheet
The company has 1.01 billion in cash and 39.99 billion in debt, giving a net cash position of -38.98 billion.
| Cash & Cash Equivalents | 1.01B |
| Total Debt | 39.99B |
| Net Cash | -38.98B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 57.60B |
| Book Value Per Share | 81.32 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 42.32%, with operating and profit margins of 8.21% and 0.58%.
| Gross Margin | 42.32% |
| Operating Margin | 8.21% |
| Pretax Margin | 0.89% |
| Profit Margin | 0.58% |
| EBITDA Margin | 12.67% |
| EBIT Margin | 8.21% |
| FCF Margin | n/a |
Dividends & Yields
NSE:JISLDVREQS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 4.01% |
| Shareholder Yield | n/a |
| Earnings Yield | 0.90% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |